Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Lipid Research

• Publication date

  1995-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 7775863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. 1978.

  2012cited by this paper
• Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist.

  1994cited by this paper
• Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.

  1993cited by this paper
• Heterozygosity for apolipoprotein E-4Philadelphia(Glu13----Lys, Arg145----Cys) is associated with incomplete dominance of type III hyperlipoproteinemia.

  1992cited by this paper
• Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.

  1992cited by this paper
• Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.

  1992cited by this paper
• The functional characteristics of a human apolipoprotein E variant (cysteine at residue 142) may explain its association with dominant expression of type III hyperlipoproteinemia.

  1992cited by this paper
• Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

  1992cited by this paper
• Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.

  1991cited by this paper
• Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E.

  1991cited by this paper
• The low-density lipoprotein receptor-related protein: double agent or decoy?

  1991cited by this paper
• Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

  1991cited by this paper
• Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.

  1991cited by this paper
• Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.

  1991cited by this paper
• 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor.

  1991cited by this paper
• Identification of heparan sulfate proteoglycan as a high affinity receptor for acidic fibroblast growth factor (aFGF) in a parathyroid cell line.

  1991cited by this paper
• Apolipoprotein E-4Philadelphia (Glu13----Lys,Arg145----Cys). Homozygosity for two rare point mutations in the apolipoprotein E gene combined with severe type III hyperlipoproteinemia.

  1991cited by this paper
• Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections.

  1990cited by this paper
• Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.

  1990cited by this paper
• The human alpha 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition.

  1990cited by this paper
• Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein.

  1990cited by this paper
• Normolipemic dysbetalipoproteinemia and hyperlipoproteinemia type III in subjects homozygous for a rare genetic apolipoprotein E variant (apoE1).

  1990cited by this paper
• Apolipoprotein E3-Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121-127.

  1989cited by this paper
• Type III hyperlipoproteinemia associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant.

  1989cited by this paper
• Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia.

  1989cited by this paper
• Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

  1989cited by this paper
• The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein

  1989cited by this paper
• The high molecular weight receptor to transforming growth factor-beta contains glycosaminoglycan chains.

  1988cited by this paper
• Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia.

  1987cited by this paper
• Immunoblotting and ligand blotting of the low‐density lipoprotein receptor of human liver, HepG2 cells and HeLa cells

  1987cited by this paper
• Genetic polymorphism in human apolipoprotein E.

  1986cited by this paper
• [49] Genetic polymorphism in human apolipoprotein E

  1986cited by this paper
• The relevance of glycosaminoglycan sulfates to Apo E induced lipid uptake by hepatocyte monolayers.

  1986cited by this paper
• Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia

  1986cited by this paper
• A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

  1984cited by this paper
• Plasma lipoproteins: apolipoprotein structure and function.

  1984cited by this paper
• Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.

  1984cited by this paper
• The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.

  1983cited by this paper
• Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.

  1983cited by this paper
• Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.

  1983cited by this paper
• Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site.

  1982cited by this paper
• Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.

  1982cited by this paper
• Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.

  1982cited by this paper
• Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E.

  1981cited by this paper
• Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.

  1981cited by this paper
• Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

  1978cited by this paper
• Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man

  1977cited by this paper
• Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

  1974cited by this paper
• A modified uronic acid carbazole reaction.

  1962cited by this paper
• The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

  1955cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Surface charge changes in spike RBD mutations of SARS-CoV-2 and its variant strains alter the virus evasiveness via HSPGs: A review and mechanistic hypothesis

  2022cites this paper
• Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene

  2022cites this paper
• Lipoproteins in the Central Nervous System: From Biology to Pathobiology.

  2022cites this paper
• Профилирование аполипопротеинов как вариант персонифицированного подхода к диа-гностике и коррекции дислипидемий

  2020cites this paper
• Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.

  2017cites this paper
• Apolipoprotein-B: The Crucial Protein of Atherogenic Lipoproteins

  2015cites this paper
• Apolipoprotein E isoforms and lipoprotein metabolism

  2014cites this paper
• Covalent and Noncovalent Bioconjugation Strategies

  2014cites this paper
• Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice

  2013cites this paper
• Computational models and methods for lipoprotein research

  2011cites this paper
• Recent insights into factors affecting remnant lipoprotein uptake

  2010cites this paper
• Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins

  2010cites this paper
• Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

  2010cites this paper
• Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk

  2010cites this paper
• Molecular processes that handle -- and mishandle -- dietary lipids.

  2008cites this paper
• Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism

  2008cites this paper
• Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

  2007cites this paper
• ALTERNATIVE SIGNALING PATHWAYS TRIGGERED BY DIFFERENT MECHANISMS OF SERPIN ENDOCYTOSIS

  2006cites this paper
• Alternative signaling pathways triggered by different mechanisms of serpin endocytosis

  2006cites this paper
• ApoE: Crossroads between Alzheimer's Disease and Atherosclerosis

  2004cites this paper
• Zelluläre Aufnahme und intrazelluläre Stoffwechselwege von Chylomikronen in Abhängigkeit der unterschiedlichen Apo E Isoformen

  2004cites this paper
• Characterization of the Heparin Binding Sites in Human Apolipoprotein E*

  2003cites this paper
• Apolipoprotein E3Basel: new insights into a highly conserved protein region

  2003cites this paper
• Medikamentöse und diätetische Therapie der Hyperlipidämie im Kindesalter: Evaluation von Wirksamkeit, Nebenwirkungen und Compliance im Patientenkollektiv der Kinder-Lipidambulanz von 1997-2000

  2002cites this paper
• Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200

  2002cites this paper
• Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.

  2001influential citation
• New Insights into the Heparan Sulfate Proteoglycan-binding Activity of Apolipoprotein E*

  2001cites this paper
• Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.

  2000cites this paper
• Perlecan Heparan Sulfate Proteoglycan

  2000cites this paper
• Familienuntersuchung von Patienten mit Mutationen des Apo E- oder LPL-Gens

  2000cites this paper
• The molecular mechanisms of inherited hypercholesterolemia

  2000cites this paper
• Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors.

  1999cites this paper
• Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes.

  1999cites this paper
• Glycation of apolipoprotein E impairs its binding to heparin: identification of the major glycation site.

  1999cites this paper
• Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.

  1999cites this paper
• Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia

  1998cites this paper
• Genetics of lipoprotein disorders.

  1998cites this paper
• Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.

  1998cites this paper
• The response-to-retention hypothesis of atherogenesis reinforced.

  1998cites this paper
• Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.

  1998influential citation
• Apolipoprotein E 2 ( Arg 136 → Cys ) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia 1

  1998cites this paper
• Molecular Diagnostics for Cardiovascular Disease

  1998cites this paper
• The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance.

  1997cites this paper
• Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism

  1997cites this paper
• Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase.

  1997cites this paper
• The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro.

  1997cites this paper
• Apolipoprotein E2 (Arg‐136→Cys), a variant of apolipoprotein E associated with late‐onset dominance of type III hyperlipoproteinaemia

  1996cites this paper
• Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease.

  1996cites this paper
• Apolipoprotein E5 (Glu212-->Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.

  1996cites this paper
• Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors.

  1996cites this paper
• Triglyceride lipases and atherosclerosis.

  1995cites this paper
• Apolipoprotein E and lipoprotein lipase co‐ordinately enhance binding and uptake of chylomicrons by human hepatocytes

  1995cites this paper